From the FDA’s Empty Seat to Chock-Full ICUs, Journalists Recap the Week’s Stories
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
Covid
461 - 480 of 1,685 Results
-
-
Low Wages and Pandemic Gut Staffing Support for Those With Disabilities
Group homes and facilities that serve people with intellectual and developmental disabilities were hurting for staffers before the pandemic. Now the nationwide job crunch and pandemic pressures are making it even worse.
By Andy Miller -
A Daily Pill to Treat Covid Could Be Just Months Away, Scientists Say
At least three promising antiviral treatments for covid-19 are being tested in clinical trials, with results expected as soon as late fall or winter.
-
Mounting Covid Deaths Fuel School Bus Drivers鈥 Fears
Since August, school bus drivers and monitors have died of covid-19 in at least 10 states, including Georgia and Florida. Masks are required on school buses, but enforcing the rules in districts without school mask mandates is especially hard to do.
By Andy Miller and Phil Galewitz -
KHN鈥檚 鈥榃hat the Health?鈥: The Autumn of Democrats鈥 Discontent
Congress is back in session with a short time to finish a long to-do list, including keeping the government operating and paying its bills. Hanging in the balance is President Joe Biden鈥檚 entire domestic agenda, including major changes proposed for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the new Texas abortion law that bans the procedure early in pregnancy is prompting action in Washington. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more. Also, Rovner interviews former FDA Commissioner Scott Gottlieb about his new book on the covid-19 pandemic.
-
Public Health Experts 鈥楩labbergasted鈥 That Biden Still Hasn鈥檛 Picked an FDA Chief
The Food and Drug Administration has been mired in controversies related to drug approvals and covid vaccines, all without a permanent leader.
-
At an Overrun ICU, 鈥榯he Problem Is We Are Running Out of Hallways鈥
Billings Clinic in Montana is past the tipping point as it looks for places to add intensive care unit beds and is on the cusp of rationing care to deal with the surge of sick covid patients in a state with significant anti-vaccination sentiment.
By Nick Ehli -
Will 鈥楧r. Disinformation鈥 Ever Face the Music?
Some of the top spreaders of spurious covid-19 and vaccine information are physicians with active medical licenses. Are medical oversight boards ready to step up to stop them?
-
Ask KHN-PolitiFact: Is My Cloth Mask Good Enough to Face the Delta Variant?
Public health experts increasingly urge people to upgrade to surgical masks, but also maintain that cloth masks still offer protection.
-
I Got a ‘Mild’ Breakthrough Case. Here’s What I Wish I’d Known.
I was miserable for five days, am fully recovered a month later and have learned even more about what we do and don鈥檛 know about covid now.
By Will Stone -
Scientists Examine Kids鈥 Unique Immune Systems as More Fall Victim to Covid
Doctors are trying to figure out why some kids become much sicker than others and, in rare cases, don鈥檛 survive.
By Liz Szabo -
Covid-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment
Patients with advanced cancer and heart disease are among those who have had to have surgeries and other treatments delayed and rescheduled as a high number of critically ill, unvaccinated covid patients strain the medical system.
-
KHN鈥檚 鈥榃hat the Health?鈥: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall 鈥 moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure鈥檚 health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interview鈥檚 KHN鈥檚 Phil Galewitz about the latest KHN-NPR 鈥淏ill of the Month鈥 installment, about two similar jaw surgeries with very different price tags.
-
How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters
With real-time data streaming in from highly specialized researchers in the U.S. and abroad, NIH scientists became convinced that boosting the covid-19 vaccine was needed to save lives, prompting the president to announce a plan with a Sept. 20 start date. Scientists at the regulatory agencies weren鈥檛 yet convinced. A meeting Friday will determine what happens next. Here鈥檚 the story from behind the scenes.
By Sarah Jane Tribble and Arthur Allen -
When Covid Deaths Are Dismissed or Stigmatized, Grief Is Mixed With Shame and Anger
After their brother died, two sisters faced a barrage of misinformation, pandemic denialism and blaming questions. Grief experts say that makes covid-19 the newest kind of "disenfranchising death."
-
Biden Releases a New Plan to Combat Covid, but Experts Say There鈥檚 Still a Ways to Go
There鈥檚 agreement that the plan includes important action items but also elements that will trigger political opposition.
By Victoria Knight and Julie Appleby -
Over Half of States Have Rolled Back Public Health Powers in Pandemic
At least 26 states have passed laws to permanently limit public health powers, a KHN investigation has found, weakening the country鈥檚 ability to fight not only the current resurgence of the pandemic but other health crises to come.
-
ICUs Are Filled With Covid 鈥 And Regret
Unvaccinated people are filling intensive care beds and dying of covid in record numbers in Tennessee and other Southern states. Many tell their nurses and doctors they regret the decision not to get the vaccine when they could.
-
Why At-Home Rapid Covid Tests Cost So Much, Even After Biden鈥檚 Push for Lower Prices
Germans pay less than $1 per test. Brits get them free. Why do Americans pay so much more? Because companies can still demand it.
-
Journalists Explain Ramifications of Theranos Trial and Texas’ New Abortion Law
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.